Greenwich is forced to look for partners

Greenwich Pharmaceuticals Inc., which has always shied away from a comprehensive partnering strategy, has done an about-face following the decision of an FDA advisory committee to recommend against marketing approval of Therafectin, a synthetic carbohydrate for rheumatoid arthritis.

The Fort Washington, Penn., company last week said it